Daniela V. Wenge

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML”.

NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML

Cell Reports(2024)10.1016/j.celrep.2024.114901

N/A

0.422DataRank · unranked

12 citations

Cynthia Martucci, Jill A. Henrich, Dana S. Neel, Sanisha Mahendra-Rajah, Hannah Rice +6 more

MEN1 mutations mediate clinical resistance to menin inhibition

Nature(2023)10.1038/s41586-023-05755-9

N/A

0DataRank · unranked

251 citations

Eytan M. Stein, Daniela V. Wenge, Sukrit Singh, Jeonghyeon Kim, Athina Apazidis +24 more

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98 -Rearranged Acute Myeloid Leukemia

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1772

N/A

0DataRank · unranked

16 citations

Emily Heikamp, Ilaria Iacobucci, Masayuki Umeda, Bright Arthur, Vibhor Mishra +37 more

p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma

EMBO Reports(2025)10.1038/s44319-025-00552-z

N/A

0DataRank · unranked

7 citations

Brandon Regalado, Sydney R. Schweber, Charlie Hatton, Daniela V. Wenge, Yanhe Wen +8 more

Menin inhibition for the treatment of acute leukemia

Seminars in Hematology(2025)10.1053/j.seminhematol.2025.08.001

N/A

0DataRank · unranked

7 citations

Scott A. Armstrong, Daniela V. Wenge